Mitoxantrone in progressive multiple sclerosis: A placebo controlled, randomized, observer blind phase III trial: Clinical results and three-year follow-up

被引:0
|
作者
Hartung, HP
Gonsette, R
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:A290 / A290
页数:1
相关论文
共 50 条
  • [21] Effect of Laparoscopic and Open Pancreaticoduodenectomy for Pancreatic or Periampullary Tumors: Three-year Follow-up of a Randomized Clinical Trial
    Qin, Tingting
    Zhang, Hang
    Pan, Shutao
    Liu, Jun
    Li, Dewei
    Chen, Rufu
    Huang, Xiaobing
    Liu, Yahui
    Liu, Jianhua
    Cheng, Wei
    Chen, Xuemin
    Zhao, Wenxing
    Li, Jingdong
    Tan, Zhijian
    Huang, Heguang
    Li, Deyu
    Zhu, Feng
    Yu, Guangsheng
    Zhou, Baoyong
    Zheng, Shangyou
    Tang, Yichen
    Ke, Jianji
    Liu, Xueqing
    Chen, Botao
    Chen, Weibo
    Ma, Hongqin
    Xu, Jian
    Liu, Yifeng
    Lin, Ronggui
    Dong, Yadong
    Yu, Yahong
    Wang, Min
    Qin, Renyi
    ANNALS OF SURGERY, 2024, 279 (04) : 605 - 612
  • [22] Rituximab in Patients with Primary Progressive Multiple Sclerosis Results of a Randomized Double-Blind Placebo-Controlled Multicenter Trial
    Hawker, Kathleen
    O'Connor, Paul
    Freedman, Mark S.
    Calabresi, Peter A.
    Antel, Jack
    Simon, Jack
    Hauser, Stephen
    Waubant, Emmanuelle
    Vollmer, Timothy
    Panitch, Hillel
    Zhang, Jiameng
    Chin, Peter
    Smith, Craig H.
    ANNALS OF NEUROLOGY, 2009, 66 (04) : 460 - 471
  • [23] Natalizumab versus placebo in patients with secondary progressive multiple sclerosis (SPMS): Results from ASCEND, a multicenter, double-blind, placebo-controlled, randomized phase 3 clinical trial
    Steiner, Deborah
    Arnold, Douglas
    Freedman, Mark
    Goldman, Myla
    Hartung, Hans-Peter
    Havrdova, Eva
    Jeffery, Douglas
    Kapoor, Raj
    Miller, Aaron
    Sellebjerg, Finn
    Amarante, Diogo
    Cadavid, Diego
    Yu, Bei
    Forrestal, Fiona
    Liu, Kezhen
    NEUROLOGY, 2016, 87 (02) : E22 - E22
  • [24] A randomized, placebo-controlled, phase 2 trial of laquinimod in primary progressive multiple sclerosis
    Giovannoni, Gavin
    Knappertz, Volker
    Steinerman, Joshua R.
    Tansy, Aaron P.
    Li, Thomas
    Krieger, Stephen
    Uccelli, Antonio
    Uitdehaag, Bernard M. J.
    Montalban, Xavier
    Hartung, Hans-Peter
    Pia Sormani, Maria
    Cree, Bruce A. C.
    Lublin, Fred
    Barkhof, Frederik
    NEUROLOGY, 2020, 95 (08) : E1027 - E1040
  • [25] One-year follow-up to a randomized controlled trial of an energy conservation course for persons with multiple sclerosis
    Mathiowetz, Virgil G.
    Matuska, Kathleen M.
    Finlayson, Marcia L.
    Luo, Ping
    Chen, Hua Yun
    INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH, 2007, 30 (04) : 305 - 313
  • [26] Cognitive-Behavioral Therapy for Caregiving Relatives of People with Dementia: Three-Year Follow-Up of a Randomized Controlled Trial
    Sittler, Mareike C.
    Topfer, Nils F.
    Meichsner, Franziska
    Theurer, Christina
    Wilz, Gabriele
    INTERNATIONAL PSYCHOGERIATRICS, 2020, 32 : 113 - 113
  • [27] Clinical follow-up study of ceramic veneered titanium restorations - Three-year results
    Kaus, T
    Probster, L
    Weber, H
    INTERNATIONAL JOURNAL OF PROSTHODONTICS, 1996, 9 (01) : 9 - 15
  • [28] Active back school, prophylactic management for low back pain: Three-year follow-up of a randomized, controlled trial
    Glomsrod, B
    Lonn, JH
    Soukup, MG
    Bo, K
    Larsen, S
    JOURNAL OF REHABILITATION MEDICINE, 2001, 33 (01) : 26 - 30
  • [29] The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial
    Nosworthy, JH
    Ebers, GC
    Vandervoort, MK
    Farquhar, RE
    Yetisir, E
    Roberts, R
    NEUROLOGY, 2001, 57 (12) : S31 - S35
  • [30] Evaluating the Role of Corticosteroid Pulse Therapy in Patients With Secondary Progressive Multiple Sclerosis Receiving Mitoxantrone: A Double Blind Randomized Controlled Clinical Trial
    Rahimdel, Abolghasem
    Zeinali, Ahmad
    Mellat, Ali
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2015, 17 (10)